NDC 61040-230 - First Aid Only Lidocaine Hydrochloride Analgesic Burn Gel
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 61040-230
- Manufacturer
- Acme United Corporation
- Effective date
- 2026-05-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE - Acme United Corporation | Acme United Corporation | 2026-05-21 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Signature Care Eye Drops Redness and Dry Eye Relief | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | Better Living Brands LLC | 901f3bbe-e1bb-4e44-879c-711e59813a7f | 2025-12-19 | Warnings | PDC6A3C0OX |
| Aspercreme with Lidocaine Foot Pain Creme | LIDOCAINE HYDROCHLORIDE | Chattem, Inc. | da82cc0e-cc39-408e-87e1-c35bb6f9f51e | 2025-12-19 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | ProPharma Distribution | 38560997-cfe4-2f9b-e063-6394a90a834b | 2025-12-18 | Warnings, Adverse reactions | V13007Z41A |
| Hand Sanitizer | BENZALKONIUM CHLORIDE | DGH Pharma, Inc. | afeccd10-c7e5-6193-e053-2995a90a9a5a | 2025-12-18 | Warnings | M003 |
| Hand Sanitizer | BENZALKONIUM CHLORIDE | DGH Pharma, Inc. | ae4311f8-fc40-38a7-e053-2a95a90ae829 | 2025-12-18 | Warnings | M003 |
| Sterile Water | WATER | ProPharma Distribution | 386a0a2f-4ff7-f128-e063-6294a90a7d4d | 2025-12-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | ProPharma Distribution | 3f2c33e5-290e-2f89-e063-6394a90aee69 | 2025-12-18 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | ProPharma Distribution | 42caf92e-6fa9-5bd7-e063-6294a90a3904 | 2025-12-18 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | ProPharma Distribution | 42d9e4cf-ca73-ec6d-e063-6394a90ae937 | 2025-12-18 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | ProPharma Distribution | 3f2bdb1f-f1c0-370d-e063-6294a90a5c50 | 2025-12-18 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | ProPharma Distribution | 43048b6b-3c83-eef4-e063-6294a90a34cb | 2025-12-18 | Warnings, Adverse reactions | V13007Z41A |
| lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 4643042c-ec95-3bad-e063-6294a90a8250 | 2025-12-18 | Warnings, Adverse reactions | V13007Z41A |
| Alcohol | ALCOHOL | Dynarex Corporation | 88c5dcbe-185f-4966-b98b-25d50299e8df | 2025-12-18 | Warnings | M003 |
| Lemon | GLYCERIN | TwinMed LLC | fc88eec0-c66c-5d6d-e053-6294a90a13d2 | 2025-12-18 | Warnings | PDC6A3C0OX |
| Povidone Iodine | POVIDONE-IODINE | TwinMed LLC | fc8cb10c-4973-c0bd-e053-6394a90a6fdb | 2025-12-18 | Warnings | M003 |
| Povidone Iodine | POVIDONE-IODINE | TwinMed LLC | fcf27cbf-9535-1356-e053-6394a90a0362 | 2025-12-18 | Warnings | M003 |
| Povidone Iodine | POVIDONE-IODINE | TwinMed LLC | fcf30b3a-c25b-7aaf-e053-6394a90affda | 2025-12-18 | Warnings | M003 |
| ZIMS MAX FREEZE | LIDOCAINE HYDROCHLORIDE AND MENTHOL, | KOBAYASHI Healthcare International, Inc. | e364ff83-4aaf-4897-a7da-06581bc321f2 | 2025-12-18 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Cardinal Health 107, LLC | 4e46cac7-00cd-4a01-ba11-9af4960cfbe9 | 2025-12-18 | Warnings, Adverse reactions | V13007Z41A |
| NAIL TREATMENT Oil Elixirs | TEA TREE OIL | Guangzhou Mizi Biotechnology Co., LTD. | 44913371-df05-05a9-e063-6294a90a5d20 | 2025-12-17 | Warnings | VIF565UC2G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.